Find a lawyerOur capabilitiesYour careerSearch
Locations
Our capabilities
News

Select language:

Locations
Our capabilities
News

Select language:

hamburger menu showcase image
  1. Our thinking
  2. News
  3. News Search
  4. Freshfields Prevails in the Second Circuit, Defeating Shareholders’ Attempt to Challenge Sumitovant’s $2.9B Acquisition of Myovant
Freshfields Prevails in the Second Circuit, Defeating Shareholders’ Attempt to Challenge Sumitovant’s $2.9B Acquisition of Myovant

On January 30, 2025, the Second Circuit affirmed the District Court’s dismissal with prejudice of a putative Section 14(a) claim seeking to undo a $2.9 billion take-private merger between Sumitovant Biopharma Limited (Sumitovant, n/k/a Sumitomo Pharma America Inc.) and Myovant Sciences Limited (Myovant).  Shareholder plaintiffs argued that Myovant’s publicly filed proxy was defective because it failed to disclose potential conflicts on the part of the Special Committee’s counsel, Skadden Arps, based on Skadden’s work for unrelated Sumitomo entities.  In January 2024, Freshfields defeated a shareholder’s effort to challenge a $2.9 billion dollar take-private merger between Sumitovant and Myovant by obtaining dismissal, with prejudice, of all claims in the Plaintiff’s class action complaint.

Plaintiff appealed and on January 30, 2025, a three-judge panel for the Second Circuit affirmed the district court was correct to dismiss the suit and declined to give plaintiff an opportunity to (yet again) amend his complaint.  The Second Circuit held that Plaintiff’s allegations “amount to speculation,” and “do not plausibly support an inference that Skadden’s advice in the Myovant transaction could have been impacted by virtue of its representation of other Sumitomo Group entities.” The Court stressed that the contentious nature of negotiations, which involved multiple offers and the consideration of a third-party bidder, undercut Plaintiff’s argument that this was a friendly deal. The Court also upheld Judge Rakoff’s decision to deny leave to amend, as Plaintiff failed to identify specific facts he wanted to include in his amended complaint if given leave to replead.

The Freshfields team included partners David Yury Livshiz and Boris Feldman, counsel Peter J. Linken and associates Elena Hadjimichael, Nathan A. Hembree, Abby Kritta and Jake Rothstein.

Our Team
New York
David LivshizPartner
Silicon Valley
Boris FeldmanPartner | Global Co-Head of Tech, Media and Telecoms
New York
Peter J. LinkenCounsel
New York
Elena HadjimichaelSenior Associate
Silicon Valley
Nathan HembreeSenior Associate
New York
Jake RothsteinAssociate
FIND US IN
All locations
NAVIGATE TO
About usYour careerOur thinkingOur capabilitiesNews
CONNECT
Find a lawyerAlumniContact us
NEED HELP
Fraud and scamsComplaintsTerms and conditions
LEGAL
AccessibilityCookiesLegal noticesTransparency in supply chains statementResponsible procurementPrivacy

© 2025 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome

Select language: